Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.490
-0.040 (-1.58%)
At close: Sep 15, 2026, 4:00 PM EDT
2.500
+0.010 (0.40%)
After-hours: Sep 15, 2026, 6:02 PM EDT
Fortress Biotech Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Fortress Biotech stock has a consensus rating of "Strong Buy" and an average price target of $11. The average 1-year stock price forecast is 341.77% higher than the current stock price, while the lowest is $5.00 (+100.80%) and the highest is $17 (+582.73%).
Price Target: $11 (+341.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Fortress Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $5 | Buy | Maintains | $5 | +100.80% | Aug 24, 2026 |
Financial Forecast
Revenue This Year
78.79M
from 63.26M
Increased by 24.55%
Revenue Next Year
113.25M
from 78.79M
Increased by 43.73%
EPS This Year
-0.40
EPS Next Year
18.60
from -0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.